Search Results 1111-1120 of 90954 for Metastasis

  1. A Study of the Combination of ACP-196 and Pembrolizumab in Subjects with Platinum-Refractory Metastatic Bladder Cancer - Mayo Clinic

    The purpose of this study is to evaluate the effect of combining ACP-196 and Pembrolizumab in subjects with platinum resistant metastatic bladder cancer.

  2. A Study to Assess the Safety and Tolerability of ADI-PEG 20 Combined with Pemetrexed and Cisplatinin in Subjects with Tumors Requiring Arginine - Mayo Clinic

    ... metastatic uveal melanoma, advanced liver cell cancer or recurrent high-grade glioma. Participation eligibility. Participant eligibility includes age, gender ...

  3. Brain tumor - Doctors and departments - Mayo Clinic

    Staff skilled in dozens of specialties work together to ensure quality care and successful recovery. Departments that treat this condition. Brain Metastases ...

  4. Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye - Mayo Clinic

    To bone or brain metastasis within 14 days before the first dose of study treatment ... No active brain metastases or epidural disease; patients with brain ...

  5. Meningioma - Doctors and departments - Mayo Clinic

    ... metastasis, Brain cancer, Choroidal melanoma. Show more areas of focus for ... metastasis, Neurofibromatosis, Meningioma, Glioblastoma, Acoustic neuroma ...

  6. Erlotinib with or without Bevacizumab in Treating Patients with Stage IV Non-Small Cell Lung Cancer with EGFR Mutations - Mayo Clinic

    ... metastases; < 5 x ULN in patients with liver or bone metastases ... Known central nervous system (CNS) disease, except for treated brain metastasis ...

  7. Spinal stenosis - Doctors and departments - Mayo Clinic

    ... metastasis, Cervical spondylotic myelopathy, Spinal fracture, Spinal metastasis, Radiculopathy, Hemangioblastoma, Spine deformity, Spondylolysis, Lumbar ...

  8. Clinical trials - Oncology (Medical)

    Phase Ib Study of Axatilimab in Combination with Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer. Rochester, Minn. This ...

  9. Study Of The Bria-IMT Regimen And CPI Vs Physicians' Choice In Advanced Metastatic Breast Cancer. (BRIA-ABC) - Mayo Clinic

    Study Of The Bria-IMT Regimen And CPI Vs Physicians' Choice In Advanced Metastatic Breast Cancer. ... metastatic or locally recurrent breast cancer (aMBC) ...

  10. A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors - Mayo Clinic

    Patient has one of the following locally advanced or metastatic, unresectable solid malignancies that is incurable: - CRC;; - Gastric or GEJ cancer;; - TNBC ...